Mario Negri Institute For Pharmacological Research
Clinical trials sponsored by Mario Negri Institute For Pharmacological Research, explained in plain language.
-
Could a vitamin a drug boost breast cancer treatment before surgery?
Disease control TerminatedThis study tested whether adding ATRA (a vitamin A-based drug) to standard hormone therapy (anastrozole) could better shrink tumors before surgery in postmenopausal women with early, hormone-sensitive breast cancer. Participants took the medications for four weeks before their sc…
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for lung cancer patients deemed 'Untreatable'
Disease control TerminatedThis study tested a three-step treatment for patients with a large, inoperable form of lung cancer who cannot receive the standard therapy. The goal was to see if starting with a drug called durvalumab plus chemotherapy could shrink tumors enough for patients to safely receive fo…
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC